Following drop after COVID-19 onset, inappropriate antibiotic prescribing is up
May 01, 2024
An initial decrease was seen in proportion with inappropriate prescription, followed by a subsequent increase.
More medical lab tests will soon face federal scrutiny, FDA says
Apr 29, 2024
Laboratory tests used by millions of Americans are soon to be classified as medical devices, and as such be regulated by the US Food and Drug Administration, the agency announced Monday.
Two-thirds of survivors of the most severe COVID-19 face impairment at one year
Apr 26, 2024
Physical, psychiatric and cognitive problems were seen in those discharged to long-term acute care hospitals.
One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
Global adult mortality rates increased during COVID-19
Mar 26, 2024
An increase was seen during the pandemic period, following a decrease between 1950 and 2019; child mortality continued to drop during the pandemic.
A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
Generalized joint hypermobility may increase risk for long COVID
Mar 26, 2024
Hypermobility also predicts greater fatigue levels.
Early antibiotics for COVID-19 can cut recovery time
Mar 25, 2024
The authors say the findings show a role for microbiome and the development of long COVID symptoms.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Burden of neurologic diagnoses lower after COVID-19 versus flu
Mar 20, 2024
Postinfection incident neurologic diagnoses were observed in 2.79 and 4.91% of the COVID-19 and influenza cohorts, respectively.